BioSpace News Archive

Battelle, which manages the U.S. National Science Foundation National Ecological Observatory Network program, is now using Starlink in a pilot test to achieve improved data transmission and service as part of an ongoing initiative to leverage new and innovative technologies to improve and enhance the operations of NEON.

Wave Life Sciences Ltd. (Nasdaq: WVE), today announced the publication of preclinical proof-of-concept data for the company’s novel ADAR-mediated RNA base editing modality in the journal Nature Biotechnology.

Curis, Inc. (NASDAQ: CRIS), today announced that a manuscript has been published in the peer-reviewed journal Gastroenterology, authored by Curis collaborators at Washington University School of Medicine in St. Louis, on the role of IRAK4 in pancreatic ductal adenocarcinoma (PDAC) and the preclinical efficacy of emavusertib (CA-4948).

Intertek, a Total Quality Assurance provider to industries worldwide, has issued its first UL 2900-2-1 certification to medical device manufacturer NuVasive, Inc. for Pulse, the company’s integrated technology platform that enables better spine surgeries.

Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced today that its unique Equinoxe® Humeral Reconstruction Prosthesis is now available for clinical use in Europe.

The move comes at a critical time as Izotropic is building devices for its future clinical studies for market authorization in the U.S. and elsewhere.

The listing of Britannia shares on the FSE represents the first step in the Company’s capital markets strategy to improve access and awareness of the Company’s shares to global investors, in particular in the UK and Europe where the bulk of Britannia’s operations are based.

TELO announced on March 28, 2021, that it had completed the feasibility stage of its ongoing clinical studies in collaboration with Mayo Clinic.

According to Precedence Research, the global 3D printing medical implants market size was valued at USD 1.59 billion in 2020 and is predicted to surpass over USD 9.06 billion by 2030.

The global artificial intelligence in diagnostics market is expected to garner growth at a compound annual growth rate (CAGR) of around 33.5% during period 2022 to 2027.